Inaktiver Wert

Santarus, Inc. Aktie

Aktien

Schlusskurs Nasdaq Andere Börsenplätze
- ^USD	-

Santarus, Inc. : Relocation Plans, Patient Enrollment, Management Appointments, and Price Movements - Research Report on HCA Holdings, Opko Health, Santarus, Coronado, and Idera	31.12.13
Santarus, Inc. : Santarus Announces Availability of Amended Tender Offer Materials	30.12.13
Santarus, Inc. : Santarus Initiates Phase IIa Study with SAN-300 in Patients with Active Rheumatoid Arthritis	23.12.13
Santarus, Inc. : Ryan & Maniskas, LLP Announces Investigation of Santarus, Inc.	11.11.13
The Ryland Group, Inc. : Dow, S&P 500 end higher for fifth straight week; financials lead	08.11.13

Sektor

	% 1. Jan.	Kap.
CSL LIMITED	+0,10 %	91,42 Mrd.
SAMSUNG BIOLOGICS CO.,LTD.	+2,76 %	41,08 Mrd.
BIOGEN INC.	-9,06 %	34,26 Mrd.
UCB	+54,31 %	25,27 Mrd.
BIOMARIN PHARMACEUTICAL INC.	-16,61 %	15,27 Mrd.
INCYTE CORPORATION	-9,14 %	12,81 Mrd.
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-12,11 %	11,6 Mrd.
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-43,61 %	11,42 Mrd.
SWEDISH ORPHAN BIOVITRUM AB	+6,22 %	9,16 Mrd.